Olenox Industries vs Radiopharm Theranostics
OLOX and RADX side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How OLOX and RADX compare
Olenox Industries grew revenue faster over the last twelve months (−0.40% versus −23.8% for Radiopharm Theranostics).
Radiopharm Theranostics scores higher on the StockData Score (6 against 1 for Olenox Industries), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | OLOX | RADX |
|---|---|---|
| Size and price | ||
| Market cap | $1.0M | – |
| Share price | $0.630 | $0.760 |
| Change, 1 year | −96.7% | −83.8% |
| Change, 5 years | −100.0% | – |
| Beta (5Y) | 0.86 | 1.05 |
| Employees | 5 | 2 |
| StockData Score | ||
| Total score | 1 | 6 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 0 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× | – |
| P/B | 0.1× | – |
| Growth | ||
| Revenue growth (TTM) | −0.40% (better) | −23.8% |
| Revenue growth, 5Y average | −19.5% | – |
| Profitability | ||
| Gross margin | −71.9% | 9.5% (better) |
| Operating margin | −353% (better) | −2052% |
| Net margin | −428% | – |
| Return on equity | −89.9% | – |
| Return on invested capital | −32.6% | – |
| Financial health | ||
| Debt / equity | 0.86 | – |
| Interest coverage | −7.0× (better) | −505.2× |
| Current ratio | 0.13 | 1.16 (better) |
| Altman Z-score | −3.78 | – |
| Piotroski F-score | 4 | – |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 1.9% | 1.4% |
| Held by insiders | 0.00% | 27.5% |
| Short interest, % of float | 15.6% | – |
Go deeper
- OLOX stock overview
- OLOX income statement
- OLOX valuation and score
- RADX stock overview
- RADX income statement
- RADX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.